In GIST mouse models, SHP2 inhibitor (SHP099) combined with imatinib significantly inhibited proliferation of imatinib‐sensitive and ‐insensitive GIST cells. This evidence concerns the gene PTPN11 and gastrointestinal stromal tumor.